Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|July 4, 2024
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an updateKylie Fletcher, Douglas B Johnson
The Oncologist|August 27, 2024
Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanomaKylie Fletcher, Saba Rehman, Rebecca Irlmeier, et al.
The Journal of Biological Chemistry|November 3, 2023
Iron homeostasis proteins Grx4 and Fra2 control activity of the Schizosaccharomyces pombe iron repressor Fep1 by facilitating [2Fe-2S] cluster removalDebolina Hati, Ariane Brault, Malini Gupta, et al.
Cancers|July 13, 2024
Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort StudyRachel S Goodman, Seungyeon Jung, Kylie Fletcher, et al.
The Oncologist|September 27, 2025
Chatbot assistance in precision oncology treatment decision-makingHannah Burnette, Kylie Fletcher, Christine Micheel, et al.
JAMA Network Open|June 4, 2025
Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic DisordersKylie Fletcher, Marc Machaalani, Razane El Hajj Chehade, et al.
Cancer Letters|June 5, 2024
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort studyKylie Fletcher, Alessio Cortellini, Teja Ganta, et al.
Pageof 1